Skip to main content
康乐卫士 logo

康乐卫士 — Investor Relations & Filings

Ticker · 920575 ISIN · CNE1000059W8 Beijing Stock Exchange Manufacturing
Filings indexed 537 across all filing types
Latest filing 2024-11-25 Declaration of Voting R…
Country CN China
Listing Beijing Stock Exchange 920575

About 康乐卫士

https://www.klws.com/

Beijing Health Guard Biotechnology Inc. is a clinical-stage biopharmaceutical company specializing in the research, development, and commercialization of innovative recombinant human vaccines. The company leverages advanced structural biology and protein engineering platforms to create a diverse pipeline of vaccine candidates. Its primary focus includes the development of high-valent human papillomavirus (HPV) vaccines, with its trivalent and nine-valent candidates in late-stage clinical trials. Additionally, the company is advancing candidates for respiratory syncytial virus (RSV), shingles, and other infectious diseases. By utilizing recombinant protein technology, Health Guard aims to provide high-quality, affordable immunization solutions to address significant unmet medical needs. Its technical expertise encompasses antigen design, high-throughput screening, and large-scale manufacturing processes.

Recent filings

Filing Released Lang Actions
2024年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the 2024 third extraordinary shareholders meeting of Beijing Kangle Weishi Biotechnology Co., Ltd. It includes information about the meeting's convening, attendance, agenda items, voting results on various board and supervisory board member elections, and legal opinions confirming the meeting's legality. The content focuses on board and supervisory personnel changes and governance matters. There is no financial data or earnings information, nor is it a report or presentation. The document is not a simple announcement of a report publication but a full disclosure of meeting resolutions and voting results. Therefore, the document best fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-11-25 Chinese
董事长、副董事长、监事会主席及高级管理人员换届公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election and appointment of the company's chairman, vice chairman, supervisory board chairman, and senior management personnel. It details the changes in the board and senior management positions, including names, shareholdings, and terms of office. There is no financial data, earnings information, or report publication mentioned. The document is clearly about management changes and governance structure updates. Therefore, it fits the category of Board/Management Information (MANG). The document length is 3090 characters, which is consistent with a detailed announcement rather than a full report.
2024-11-25 Chinese
公司章程
Governance Information Classification · 100% confidence The document is titled as the "章程" (Articles of Association or Company Bylaws) of Beijing Health Guard Biotechnology Inc. It contains detailed provisions about the company's organizational structure, shareholder rights, board of directors, management, share issuance, share transfer, shareholder meetings, voting procedures, and other governance matters. It references relevant laws and regulations such as the Company Law, Securities Law, and Beijing Stock Exchange listing rules. The content is a comprehensive governance document that sets out the internal rules and procedures of the company rather than financial results, audit opinions, or meeting announcements. It is not a report of financial performance, nor an announcement of voting results or management changes. It is a governance document detailing the company's internal rules and board structure. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed content confirm it is the full governance document, not a brief announcement or summary.
2024-11-25 Chinese
关于选举第五届董事会专门委员会委员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the election of members to the company's fifth board of directors' specialized committees. It details the composition of various committees such as the Audit Committee, Strategy Committee, Nomination Committee, and Remuneration and Assessment Committee. The content focuses on board/management structural changes and appointments. There is no financial data, no mention of financial results, no report publication, or regulatory filings. This fits the category of Board/Management Information (MANG). The document length is short and it is a formal announcement of board committee appointments, not a report or presentation.
2024-11-25 Chinese
风险管理制度(2024年制定)
Governance Information Classification · 95% confidence The document is titled '风险管理制度(2024 年制定)' which translates to 'Risk Management System (2024 Edition)'. It is a detailed internal policy document approved by the company's board of directors on November 25, 2024. The content outlines the company's risk management framework, organizational responsibilities, risk categories, and procedures for risk identification, assessment, control, monitoring, and reporting. There is no indication that this is a financial report, earnings release, or regulatory filing. It is not an announcement of a report but the actual policy document itself. The document relates to governance and internal control practices rather than financial results or external disclosures. Therefore, the most appropriate classification is Governance Information (CGR). The document length (4905 characters) and detailed content support this classification with high confidence.
2024-11-25 Chinese
第五届董事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is a detailed announcement of the resolutions passed at the first meeting of the fifth board of directors of Beijing Kangle Weishi Biotechnology Co., Ltd. It includes information about the election and appointment of board members and senior management, meeting attendance, voting results, and governance-related decisions. The document references compliance with company law, stock exchange listing rules, and company articles of association. It does not contain financial statements or financial performance data, nor is it a transcript or presentation. The content focuses on board and management changes and governance matters. Therefore, the document fits the category of Board/Management Information (MANG). The document length is under 5,000 characters and is a full announcement, not a brief notice or report publication announcement.
2024-11-25 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.